Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban for Painful Venous Malformations With Localized Intravascular Coagulation
2024-511930-11-00Phase 2Authorised
- Sponsor
- Oslo University Hospital
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of apixaban in venous malformation (VM) (2 arms), sponsored by Oslo University Hospital. Planned start Jul 2024; status: authorised.
02
Drugs
apixaban
03
Conditions
venous malformation (VM)
Beyond the preview
Go deeper on 2024-511930-11-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511930-11-00.